ClinicalTrials.Veeva

Menu

Gestational Diabetes in Central Asia: Prevalence and Management (GESDICA)

L

Ludwig Maximilian University of Munich

Status

Completed

Conditions

Gestational Diabetes Mellitus

Treatments

Other: Observation

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02436551
GESDICA

Details and patient eligibility

About

Evaluate prevalence and management of gestational diabetes in Tajikistan in two different settings (one rural and one urban).

Enrollment

3,200 patients

Sex

Female

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnancy

Exclusion criteria

  • known diabetes mellitus

Trial design

3,200 participants in 1 patient group

Pregnant women in Tajikistan
Treatment:
Other: Observation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems